Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-14-000566
Filing Date
2014-11-10
Accepted
2014-11-10 16:09:18
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-093014.htm 10-Q 583503
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 12437
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 12768
4 EXHIBIT 32 ex32.htm EX-32 9085
  Complete submission text file 0001079973-14-000566.txt   5304460

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20140930.xml EX-101.INS 768388
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20140930.xsd EX-101.SCH 26826
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20140930_cal.xml EX-101.CAL 44570
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20140930_def.xml EX-101.DEF 142457
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20140930_lab.xml EX-101.LAB 579847
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20140930_pre.xml EX-101.PRE 288990
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 141208742
SIC: 2835 In Vitro & In Vivo Diagnostic Substances